PAR4 (Protease-Activated Receptor 4): PARticularly Important 4 Antiplatelet Therapy

Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):287-289. doi: 10.1161/ATVBAHA.117.310550.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Humans
  • Platelet Aggregation Inhibitors*
  • Receptors, Thrombin*
  • Thrombosis

Substances

  • Platelet Aggregation Inhibitors
  • Receptors, Thrombin
  • protease-activated receptor 4